|
| Andrei Gafita | David Geffen School of Medicine (M.R.), University of California-Los Angeles, Johns Hopkins University School of Medicine, Universite Grenoble Alpes, INSERM, Technical University Munich, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Jeremie Calais | David Geffen School of Medicine (M.R.), University of California-Los Angeles, Johns Hopkins University School of Medicine, Universite Grenoble Alpes, INSERM, Technical University Munich, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Matthew B Rettig | David Geffen School of Medicine (M.R.), University of California-Los Angeles, Johns Hopkins University School of Medicine, Universite Grenoble Alpes, INSERM, Technical University Munich, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, IRCCS Azienda Ospedaliero-Universitaria di Bologna |